The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling

Emma S Winkler1, Swathi Shrihari2, Barry L Hykes3

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell
|July 16, 2020
PubMed

Insights

The gut microbiome influences Chikungunya virus (CHIKV) infection severity. Restoring specific gut bacteria or their metabolites enhances antiviral immunity, reducing CHIKV spread and transmission.

Area of Science:

  • Virology
  • Immunology
  • Microbiome Research

Background:

  • Chikungunya virus (CHIKV) is an emerging alphavirus causing widespread infections.
  • Factors influencing CHIKV disease severity are not fully understood.
  • The role of the gut microbiome in CHIKV pathogenesis is largely unexplored.

Purpose of the Study:

  • To investigate the impact of the intestinal microbiome on CHIKV infection and disease outcome.
  • To elucidate the mechanisms by which the microbiome modulates antiviral immunity against CHIKV.

Main Methods:

  • Experiments were conducted in germ-free mice and antibiotic-treated mice with depleted gut microbiomes.
  • Chikungunya virus (CHIKV) infection and spread were monitored.
  • Toll-like receptor 7 (TLR7)-MyD88 signaling, type I interferon (IFN) production, and IFN-stimulated gene expression in monocytes were analyzed.
  • Microbiome reconstitution was performed using Clostridium scindens or deoxycholic acid.

Main Results:

  • Depletion of the gut microbiome led to increased CHIKV infection and spread within 24 hours.
  • Altered microbiomes impaired TLR7-MyD88 signaling in plasmacytoid dendritic cells (pDCs), reducing type I IFN production.
  • Circulating monocytes became permissive to CHIKV infection due to reduced IFN-stimulated gene expression.
  • Reconstitution with Clostridium scindens or deoxycholic acid restored pDC- and MyD88-dependent type I IFN responses, restricting CHIKV infection and transmission.

Conclusions:

  • Symbiotic intestinal bacteria play a crucial role in modulating antiviral immunity against CHIKV.
  • A bile acid-pDC-IFN signaling axis, influenced by gut bacteria, controls viremia, dissemination, and transmission of CHIKV.
  • Targeting the gut microbiome or its metabolites represents a potential strategy for managing CHIKV infections.